Medical IPO defies the cold wave! AI spinal surgery company Carlsmed rushes for US stock IPO aiming to raise $107.2 million

Medical technology company Carlsmed Inc. plans to raise up to $107.2 million through an initial public offering (IPO) in the United States. The company utilizes artificial intelligence to personalize spinal surgeries and intends to issue 6.7 million shares, priced between $14 and $16 per share, with a market capitalization of approximately $424.3 million. In the first three months of 2025, Carlsmed achieved revenue of $10.2 million and a net loss of $5.7 million. Despite the continued downturn in IPO financing in the healthcare sector, Carlsmed's technology platform has been approved for lumbar fusion surgeries and plans to develop a version for cervical fusion surgeries